Archive for January, 2009

Sexual Health

Saturday, January 17th, 2009

We want to share with you helpful strategies and techniques to integrate into your sexual health, now and in the years ahead, features that we have learned from our many years of teaching and clinical experience with men and couples. Chapter 2, “Healthy Th inking About Male Sexuality,” summarizes important knowledge for healthy sex. We explain how to organize your thinking (cognitions), understand your feelings (emotions), as well as wisely manage your actions (behaviors).

Among 10 features to integrate into your personal sexual style are appreciating the multiple purposes for sex, how to use the three styles of sexual arousal, the importance of regulating your sex drive, viewing sex through the lens of being an intimate team, and understanding why and how Good-Enough Sex is the best sex model. Chapter 3, “Boys to Men: What Is Normal and Healthy?” describes how we learn about sex as boys and summarizes behaviors of children, adolescents, and young adults. Th ese data help you understand normal and healthy developmental sexuality and the infl uences and experiences that have formed who you are as a man.

Acomplia Online For Weight Loss

Saturday, January 10th, 2009

Acomplia Online For Weight Loss

Obesity may be caused by hypothyroidism, genetics, poor diet, lack of exercise, poor lifestyle habits, medication side effects and excess alcohol intake. A lot of precautions have to be taken while prescribing medicines for obesity [acomplia online]. These medicines are not generally suggested for treating obesity because of the risks that outweigh their benefits. The common medicines include diethylpropion, fenfluramine, mazindol, and phentermine.An experienced health practitioner can give you information about obesity treatments, including weight loss pills and supplements, surgeries and their complications, etc. Many educational campaigns about the benefits of improved diets and better physical activity are the other sources to find right obesity help [acomplia]. Websites created by health organizations and social service groups are devoted to providing relevant information regarding obesity issues.The main reason for finding obesity help is the increase of poor life-long nutrition choices and the lack of exercise. Poor nutrition is the cause of not only obesity but numerous other diseases. Good obesity help will help you feel healthy, perform daily activities better, and empower you to eradicate the need for obesity help in the future [acomplia online]. If you follow a sound, healthy nutrition plan now and exercise on a regular basis using a good quality fitness program, you’re likely to get rid of the need for obesity help [buy acomplia online].There is, therefore, a great deal if excitement over Merck’s new diet drug taranabant. The results from the second phase of testing were encouraging and now after another two years of testing it seems that the results for phase three may be equally exciting, though the final report is yet to be published.Researchers announced that study participants taking varying doses of taranabant lost 8 to 14 pounds over a 12-week period. There was one question, however, which still remains unanswered. Does taranabant have less significant side effects than rimonabant? Both drugs work in a similar way, by targeting particular receptors in the brain. Acomplia, however, was not approved by the FDA after concerns were raised over its psychiatric side effects which may include depression and suicidal thoughts in patients prone to mental health problems. So how does taranabant compare? Initial feedback seems to suggest that between one-fifth and one-third of patients had experienced adverse side effects which included depressed mood, irritability, anger, mood swings and insomnia [acomplia online]. Unlike rimonabant, however, patients reported no suicidal thoughts though it was conceded that the question had not been asked in a systematic way.

Buy Acomplia Online Diet Drug

There will, of course, have to be more conclusive evidence provided before the FDA grants approval to the new drug. The company expects the phase III report to be published later this year and for taranabant to be submitted for FDA approval before the end of 2008. Taranabant will also be submitted to the European Medicines Agency although it is believed that Merck wants to get it approved in the US first.Taranabant is a CB1 receptor reverse agonist which is slightly different form Acomplia, which is a CB1 receptor antagonist. Although they are both targeting the endocannabinoid system, the slightly different way in which they work could be crucial. Acomplia was approved for use in the UK in June 2006 and since then it has helped a number of people to lose weight but many have been disappointed by the lack of progress and ceased treatment after one or two months [acomplia online]. Many also found the cost of this medication on private prescription to be prohibitive. The unfortunate thing is that all new weight loss drugs seem to get hyped up by the media and this ultimately leads to disappointment as the results, for most people, rarely match the hype. It cannot be emphasised enough that weight loss medications should only ever be used as an adjunct to diet and exercise. Obesity is a burgeoning problem in gthe West and medications that get regulatory approval do work but there has to be some effort on the part of the patient.